The Shanghai Aladdin Biochemical Technology Co.,Ltd fundraising project has been repeatedly delayed, raising market concerns, as the leading biological reagent company faces construction difficulties.
① This is not the first time that Shanghai Aladdin Biochemical Technology Co., Ltd.'s three major projects have not met expectations. As early as March 8, 2024, Aladdin had issued a similar announcement regarding the delay of fundraising projects. ② Currently, some domestic enterprises are rapidly seizing the market and expanding their revenue scale mainly through representing foreign brands, even resorting to Low Stock Price competition, which has lowered the competition threshold in the Industry.
[Data View] Institutions have been continuously increasing their positions in Asia Vets, while powerful speculators are selling Hainan Huatie for over 0.6 billion.
① The AI all-in-one machine Concept stock, Zhimei Asia Vets, received over 80 million from Institutions buying in, and this stock has been significantly bought by Institutions for two consecutive days. ② The computing power Concept stock Hainan Huatie has been Sold for 0.662 billion by GTJA's Shanghai Haiyang West Road branch.
Driven by 'technical cost reduction + policy advantages', Analysts are Bullish on the opportunities for the scaled explosion of hydrogen energy.
① Recently, the "Hydrogen Teng" Fuel Cell Energy product equipment successfully generated power in Antarctica, marking the first application of hydrogen energy technology in Antarctic conditions globally. ② Sinolink pointed out that the domestic market is developing rapidly due to policy consistency, the speed of technology cost reduction, and regional cluster advantages, closely focusing on "technology cost reduction + policy advantages" to seize the opportunity for hydrogen energy to transition from demonstration to large-scale explosion.
Former TJ DaRenTang Chairman Zhang Mingrui has taken over as General Manager of Hainan Huluwa Pharmaceutical Group, responsible for the company's overall Operation work | Quick read announcement
① Former TJ DaRenTang Chairman Zhang Mingrui has been appointed General Manager of Hainan Huluwa Pharmaceutical Group. Company sources indicate, "Chairman Liu Jingping will primarily focus on the work related to the Board of Directors in the future, while General Manager Zhang Mingrui will be responsible for the company's overall Operation." ② Company sources also noted that this year marks the year of Hainan's customs closure, and the company is facing significant opportunities for strategic development. The company's invitation for Mr. Zhang is also strategical.
The market is still in a short-term retreat phase; after the peak of Solid State Battery, disagreements may intensify.
Track the entire lifecycle of the main Sector.
Star Evening News | Yijixin plans to acquire the controlling interest in Huimao Micro, and Xinxiangwei intends to purchase the controlling interest in Aixiangsheng.
① The "Action Plan for Accelerating the Development of the AI Terminal Industry in Shenzhen (2025-2026)" has been issued; ② The manned flight mission for 2025 has been announced; ③ The China Academy of Information and Communications Technology will hold a special seminar on promoting the AI glasses industry on March 12.